100 related articles for article (PubMed ID: 29594966)
1. T cell receptor-β J usage, in combination with particular HLA class II alleles, correlates with better cancer survival rates.
Callahan BM; Tong WL; Blanck G
Immunol Res; 2018 Apr; 66(2):219-223. PubMed ID: 29594966
[TBL] [Abstract][Full Text] [Related]
2. TRBV and TRBJ usage, when paired with specific HLA alleles, associates with distinct head and neck cancer survival rates.
Arndt MF; Koohestani DM; Chobrutskiy BI; Mihyu MM; Diaz M; Gozlan EC; Yeagley M; Zaman S; Roca AM; Blanck G
Hum Immunol; 2020 Dec; 81(12):692-696. PubMed ID: 32950267
[TBL] [Abstract][Full Text] [Related]
3. T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns.
Callahan BM; Yavorski JM; Tu YN; Tong WL; Kinskey JC; Clark KR; Fawcett TJ; Blanck G
Cancer Immunol Immunother; 2018 Jun; 67(6):885-892. PubMed ID: 29508024
[TBL] [Abstract][Full Text] [Related]
4. T-cell receptor V and J usage paired with specific HLA alleles associates with distinct cervical cancer survival rates.
Roca AM; Chobrutskiy BI; Callahan BM; Blanck G
Hum Immunol; 2019 Apr; 80(4):237-242. PubMed ID: 30684568
[TBL] [Abstract][Full Text] [Related]
5. Interaction between certain major histocompatibility complex class II and T-cell receptor V beta alleles promotes the antibody production to extractable nuclear antigen-related peptides.
Youinou P; Semana G; Muller S; Piette JC; Guillevin L; Jouquan J; Salmon D; Salmon J; Genetet B; Bach JF
Hum Immunol; 1997 Jan; 52(1):12-21. PubMed ID: 9021405
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium bovis BCG scar status and HLA class II alleles influence purified protein derivative-specific T-cell receptor V beta expression in pulmonary tuberculosis patients from southern India.
Shanmugalakshmi S; Dheenadhayalan V; Muthuveeralakshmi P; Arivarignan G; Pitchappan RM
Infect Immun; 2003 Aug; 71(8):4544-53. PubMed ID: 12874334
[TBL] [Abstract][Full Text] [Related]
7. Specific HLA alleles, paired with TCR V- and J-gene segment usage, link to distinct multiple myeloma survival rates.
Huda TI; Mihyu M; Gozlan EC; Arndt MF; Diaz MJ; Zaman S; Chobrutskiy BI; Blanck G
Leuk Lymphoma; 2021 Jul; 62(7):1711-1720. PubMed ID: 33622167
[TBL] [Abstract][Full Text] [Related]
8. Thymic repertoire selection by superantigens: presentation by human and mouse MHC molecules.
Simpson E; Takacs K; Altmann DM
Thymus; 1994; 23(1):1-13. PubMed ID: 7863543
[TBL] [Abstract][Full Text] [Related]
9. Collagen Specific T-Cell Repertoire and HLA-DR Alleles: Biomarkers of Active Refractory Rheumatoid Arthritis.
Di Sante G; Tolusso B; Fedele AL; Gremese E; Alivernini S; Nicolò C; Ria F; Ferraccioli G
EBioMedicine; 2015 Dec; 2(12):2037-45. PubMed ID: 26844284
[TBL] [Abstract][Full Text] [Related]
10. TCR gene segment usage and HLA alleles that are associated with cancer survival rates also represent racial disparities.
Angelakakis G; Serraneau KS; Barker VR; Callahan BM; Tong WL; Zaman S; Huda TI; Blanck G
Int J Immunogenet; 2023 Apr; 50(2):41-47. PubMed ID: 36585798
[TBL] [Abstract][Full Text] [Related]
11. Summer-type hypersensitivity pneumonitis. T-cell receptor V gene usage in BALF T-cells from 3 cases in one family.
Shigematsu M; Nagai S; Nishimura K; Izumi T; Eklund AG; Grunewald J
Sarcoidosis Vasc Diffuse Lung Dis; 1998 Sep; 15(2):173-7. PubMed ID: 9789896
[TBL] [Abstract][Full Text] [Related]
12. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
13. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.
Clark KR; Tong WL; Callahan BM; Yavorski JM; Tu YN; Blanck G
Int J Immunogenet; 2019 Feb; 46(1):31-37. PubMed ID: 30474304
[TBL] [Abstract][Full Text] [Related]
14. Restricted usage of T cell receptor V alpha/J alpha gene segments with different nucleotide but identical amino acid sequences in HLA-DR3+ sarcoidosis patients.
Grunewald J; Hultman T; Bucht A; Eklund A; Wigzell H
Mol Med; 1995 Mar; 1(3):287-96. PubMed ID: 8529107
[TBL] [Abstract][Full Text] [Related]
15. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Tong WL; Callahan BM; Tu YN; Zaman S; Chobrutskiy BI; Blanck G
Breast Cancer Res Treat; 2019 Jan; 173(1):167-177. PubMed ID: 30229447
[TBL] [Abstract][Full Text] [Related]
16. Association of HLA class I antigens and HLA class II alleles with vitiligo in a Turkish population.
Taştan HB; Akar A; Orkunoğlu FE; Arca E; Inal A
Pigment Cell Res; 2004 Apr; 17(2):181-4. PubMed ID: 15016308
[TBL] [Abstract][Full Text] [Related]
17. Human leukocyte antigen class I allelic and haplotype loss in squamous cell carcinoma of the head and neck: clinical and immunogenetic consequences.
Grandis JR; Falkner DM; Melhem MF; Gooding WE; Drenning SD; Morel PA
Clin Cancer Res; 2000 Jul; 6(7):2794-802. PubMed ID: 10914726
[TBL] [Abstract][Full Text] [Related]
18. [Frequency of HLA alleles class I and II in a cohort of northwestern Colombian patients with spondyloarthritis].
Velásquez EP; Quintero JC; Aristizábal BH; Rincón OL; Velásquez CJ; Pinto LF; Márquez JD
Biomedica; 2012; 32(1):43-51. PubMed ID: 23235786
[TBL] [Abstract][Full Text] [Related]
19. Preferential usage of T cell antigen receptor V region gene segment V beta 5.1 by Borrelia burgdorferi antigen-reactive T cell clones isolated from a patient with Lyme disease.
Lahesmaa R; Shanafelt MC; Allsup A; Soderberg C; Anzola J; Freitas V; Turck C; Steinman L; Peltz G
J Immunol; 1993 May; 150(9):4125-35. PubMed ID: 7682589
[TBL] [Abstract][Full Text] [Related]
20. Minor histocompatibility antigen DDX3Y induces HLA-DQ5-restricted T cell responses with limited TCR-Vbeta usage both in vivo and in vitro.
Laurin D; Spierings E; van der Veken LT; Hamrouni A; Falkenburg JH; Souillet G; Vermeulen C; Farre A; Galambrun C; Rigal D; Bertrand Y; Goulmy E; Eljaafari A
Biol Blood Marrow Transplant; 2006 Nov; 12(11):1114-24. PubMed ID: 17085304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
